AAAAAA
Results:
1-22
|
Results: 22
Authors:
Sullivan, DG
Kim, SS
Wilson, JJ
Stehman-Breen, C
Gretch, DR
Citation: Dg. Sullivan et al., Investigating hepatitis C virus heterogeneity in a high prevalence settingusing heteroduplex tracking analysis, J VIROL MET, 96(1), 2001, pp. 5-16
Authors:
Nolte, FS
Fried, MW
Shiffman, ML
Ferreira-Gonzalez, A
Garrett, CT
Schiff, ER
Polyak, SJ
Gretch, DR
Citation: Fs. Nolte et al., Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICORhepatitis C virus tests, J CLIN MICR, 39(11), 2001, pp. 4005-4012
Authors:
Cotler, SJ
Ganger, DR
Kaur, S
Rosenblate, H
Jakate, S
Sullivan, DG
Ng, KW
Gretch, DR
Jensen, DM
Citation: Sj. Cotler et al., Daily interferon therapy for hepatitis C virus infection in liver transplant recipients, TRANSPLANT, 71(2), 2001, pp. 261-266
Authors:
Polyak, SJ
Khabar, KSA
Paschal, DM
Ezelle, HJ
Duverlie, G
Barber, GN
Levy, DE
Mukaida, N
Gretch, DR
Citation: Sj. Polyak et al., Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response, J VIROLOGY, 75(13), 2001, pp. 6095-6106
Authors:
Polyak, SJ
Khabar, KSA
Rezeiq, M
Gretch, DR
Citation: Sj. Polyak et al., Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy, J VIROLOGY, 75(13), 2001, pp. 6209-6211
Authors:
Cotler, SJ
Wartelle, CF
Larson, AM
Gretch, DR
Jensen, DM
Carithers, RL
Citation: Sj. Cotler et al., Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C, J VIRAL HEP, 7(3), 2000, pp. 211-217
Authors:
Carithers, RL
Marquardt, A
Gretch, DR
Citation: Rl. Carithers et al., Diagnostic testing for hepatitis C, SEM LIV DIS, 20(2), 2000, pp. 159-171
Authors:
Chang, M
Marquardt, AP
Wood, BL
Williams, O
Cotler, SJ
Taylor, SL
Carithers, RL
Gretch, DR
Citation: M. Chang et al., In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease, J VIROLOGY, 74(2), 2000, pp. 944-955
Authors:
Nousbaum, JB
Polyak, SJ
Ray, SC
Sullivan, DG
Larson, AM
Carithers, RL
Gretch, DR
Citation: Jb. Nousbaum et al., Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy, J VIROLOGY, 74(19), 2000, pp. 9028-9038
Authors:
Polyak, SJ
Nousbaum, JB
Larson, AM
Cotler, S
Carithers, RL
Gretch, DR
Citation: Sj. Polyak et al., The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon, J INFEC DIS, 182(2), 2000, pp. 397-404
Authors:
Dufour, DR
Lott, JA
Nolte, FS
Gretch, DR
Koff, RS
Seeff, LB
Citation: Dr. Dufour et al., Diagnosis and monitoring of hepatic injury. I. Performance characteristicsof laboratory tests, CLIN CHEM, 46(12), 2000, pp. 2027-2049
Authors:
Dufour, DR
Lott, JA
Nolte, FS
Gretch, DR
Koff, RS
Seeff, LB
Citation: Dr. Dufour et al., Diagnosis and monitoring of hepatic injury. II. Recommendations for use oflaboratory tests in screening, diagnosis, and monitoring, CLIN CHEM, 46(12), 2000, pp. 2050-2068
Authors:
Cotler, SJ
Taylor, SL
Gretch, DR
Bronner, MP
Rizk, R
Perkins, JD
Carithers, RL
Citation: Sj. Cotler et al., Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients, AM J GASTRO, 95(3), 2000, pp. 753-759
Authors:
Rosen, HR
Gretch, DR
Citation: Hr. Rosen et Dr. Gretch, Hepatitis C virus: current understanding and prospects for future therapies, MOL MED TOD, 5(9), 1999, pp. 393-399
Authors:
Gerotto, M
Dal Pero, F
Sullivan, DG
Chemello, L
Cavalletto, L
Polyak, SJ
Pontisso, P
Gretch, DR
Alberti, A
Citation: M. Gerotto et al., Evidence for sequence selection within the non-structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon-alpha, J VIRAL HEP, 6(5), 1999, pp. 367-372
Authors:
Polyak, SJ
Paschal, DM
McArdle, S
Gale, MJ
Moradpour, D
Gretch, DR
Citation: Sj. Polyak et al., Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication, HEPATOLOGY, 29(4), 1999, pp. 1262-1271
Authors:
Cotler, SJ
Emond, MJ
Gretch, DR
Wilson, JJ
Lin, M
Bronner, MP
Kowdley, KV
Citation: Sj. Cotler et al., Relationship between iron concentration and hepatitis C virus RNA level inliver tissue, J CLIN GAST, 29(4), 1999, pp. 322-326
Authors:
Gerotto, M
Sullivan, DC
Polyak, SJ
Chemello, L
Cavalletto, L
Pontisso, P
Alberti, A
Gretch, DR
Citation: M. Gerotto et al., Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C, J VIROLOGY, 73(9), 1999, pp. 7241-7247
Authors:
Rosen, HR
Hinrichs, DJ
Gretch, DR
Koziel, MJ
Chou, S
Houghton, M
Rabkin, J
Corless, CL
Bouwer, HGA
Citation: Hr. Rosen et al., Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation, GASTROENTY, 117(4), 1999, pp. 926-932
Authors:
Rosen, HR
Chou, SW
Sasaki, AW
Gretch, DR
Citation: Hr. Rosen et al., Molecular epidemiology of hepatitis C infection in US veteran liver transplant recipients: Evidence for decreasing relative prevalence of genotype 1B, AM J GASTRO, 94(10), 1999, pp. 3015-3019
Authors:
Pawlotsky, JM
Gretch, DR
Citation: Jm. Pawlotsky et Dr. Gretch, Molecular tools for the treatment of hepatitis C, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 103-113
Authors:
Gretch, DR
Polyak, SJ
Citation: Dr. Gretch et Sj. Polyak, The quasispecies nature of hepatitis C virus: research methods and biological implications, HEPATITIS C VIRUS: GENETIC HETEROGENEITY AND VIRAL LOAD, 1997, pp. 57-69
Risultati:
1-22
|